BioSpace News Archive

Biolog-id has completed phase one of implementing its value-chain optimization solution in a large medical center and level II trauma center in North Carolina.

Todos Medical, Ltd. today announced that it has received two Notices of Allowance from the United States Patent & Trademark Office (USPTO) for patent applications covering the Company’s Total Biochemical Infrared Analysis (TBIA) Fourier Transformed Infrared (FTIR) pan-cancer blood diagnostics platform.

Seelos Therapeutics, Inc. today announced it will collaborate with the Sean M. Healey & AMG Center for ALS in an Expanded Access Program (EAP) that will be fully funded by a grant from the National Institute of Neurological Disorders and Stroke (NINDS) under the ACT for ALS.

NeoSpectra by Si-Ware today announced the release of the first-of-its-kind marketplace of near-infrared (NIR) calibration models with the launch of the NeoSpectra LabStore.

Cytokinetics, Incorporated presented new data on the reduction and withdrawal of background standard of care medical therapy in patients treated with aficamten in REDWOOD-HCM OLE in a Late Breaking Clinical Trials session at the 2022 HCM Society Scientific Sessions, the inaugural scientific sessions of this newly launched professional medical society, held in National Harbor, MD.

Mentice AB a leading supplier of high-technology solutions for simulation in the medical sector with focus on endovascular procedures, announces that the nomination committee for the company’s Annual General Meeting 2023 has been appointed.

Toragen Inc., a San Diego-based biotechnology company focused on developing, repurposing and commercializing uniquely selective drugs targeting cancers caused by the human papillomavirus, announced that it has reached its initial goal to raise at least $5M in a Series Seed round of financing.

Sensei Biotherapeutics, Inc. presented additional preclinical data on SNS-101, a monoclonal antibody targeting the immune checkpoint VISTA, at the Sixth Annual CRI-ENCI-AACR International Cancer Immunotherapy Conference: Translating Science into Survival.

Nanoscope Therapeutics Inc. announced that management will present at Chardan’s 6th Annual Genetic Medicines Conference on Monday, October 3, 2022, in New York.

Hanger, Inc., a leading provider of orthotic and prosthetic patient care services and solutions, announced that its stockholders approved at a special meeting the acquisition of Hanger by Patient Square Capital, a leading dedicated health care investment firm.